Given a paragraph and a claim, classify it this way: If the claim contradicts the evidence present in the paragraph, classify the claim as '0'. If the claim has multiple supporting *AND* contradicting evidences, classify the claim as '1'. If the claim has supporting evidence and the paragraph is in overall favor of the claim, then classify the claim as '2'.

Example Input: Paragraph: CES is allowing space for sex tech companies as a one-year trial. At the show, such companies were scattered throughout the health and wellness section, near startups pitching fitness trackers and infrared saunas. Lora DiCarlo, a startup that pushed for changes after organizers revoked its award, showed off its Osé robotic “personal massager.” It’s one of a dozen companies at the show focused on vibrators, lube dispensers and other sex tech products. Founders of these startups say their products are about empowerment and wellness for women, something they say has often been overlooked in tech. The historically male-dominated tech trade show has received criticism in past years for having an all-male lineup of speakers and for previously allowing scantily clad “booth babes,” fostering a “boys’ club” reputation. Besides allowing sex tech, CES organizers brought in an official “equality partner,” The Female Quotient, to help ensure gender diversity. The Female Quotient, which trains companies in equality practices, will hold a conference for women during the four-day show, which opened Tuesday. “It’s been a process,” said Gary Shapiro, the head of the Consumer Technology Association, which puts on CES. It’s been a longer process for many sex tech companies to convince investors that they are part of a growing trend that has enough customers. Much of the push has come from the startups’ female founders and from younger consumers who talk more openly about sexuality. As with other technologies, some exhibitors including Lora DiCarlo had prominent booths at CES, while others such as the wearable vibrator company Crave were tucked away. Crave’s exhibit included a camper with a “Build-a-Vibe-Workshop,” where attendees could get an engraved vibrator to wear around their neck. Sex tech has existed in some form for decades. But the gates really began to open in 2016, said Andrea Barrica, founder of sex education site O.school. That year, several other “fem tech” companies made progress in areas such as menstruation and menopause. Those paved the way for sex tech to grow and get investors interested. “Larger institutions are starting to take note, all the way from VC firms to large Fortune 100 companies,” said Barrica, who recently published the book “Sextech Revolution: The Future of Sexual Wellness.” Large institutions like CES had no choice but to look at sex tech, she said. The journey hasn’t been easy. Sex tech founders, many of them women, recount being turned down by dozens of investors. They faced decency arguments and entrenched corporate standards that equated them with porn. But investors are becoming more receptive, said Cindy Gallop, a former advertising executive turned sex tech entrepreneur and founder of the website MakeLoveNotPorn. “It’s entirely because of our refusal to allow the business world to put us down,” she said. Founders insist that their devices — ranging from vibrators to lube dispensers to accessories — have effects outside the bedroom. “Sexual health and wellness is health and wellness,” said Lora DiCarlo, CEO and founder of the company of the same name. “It does way more than just pleasure. It’s immediately connected to stress relief, to better sleep, to empowerment and confidence.” DiCarlo’s $290 Osé device has gotten $3 million worth of advance sales, bolstered in part by the attention it received after CES organizers overturned a decision by an independent panel of judges to give the vibrator a prestigious Innovation Honoree Award in the robotics and drone category. The organizers, CTA, told the company it reserved the right to rescind awards for devices deemed “immoral, obscene, indecent, profane or not in keeping with CTA’s image.” DiCarlo and other female founders pushed back for banning them but allowing humanoid sex robots meant to serve men the previous year. Following criticism, CES organizers ultimately  reinstated the award and apologized. A few months later, the show announced policy changes such as a dress code to prevent skimpy outfits and new “Innovation for All” sessions with senior diversity officials. Osé began shipping to customers this month. DiCarlo said the company is planning to introduce new devices, including less expensive options. Sex tech companies still face major barriers to growth. Polly Rodriguez, CEO of sexual wellness company Unbound, said the company is profitable and customers are more open about buying products than they once were. But she said she still faces roadblocks advertising on social media, and many traditional investors snub the company. “Things are better, but there’s just still this genuine fear of female sexuality more broadly within the institutional side of technology,” she said. And while Gallop offered to speak at CES, conference organizers declined, saying sex tech was not a part of its conference programming. ___ AP Business Writer Joseph Pisani contributed to this report. ___ AP’s CES coverage: https://apnews.com/Consumerelectronics Claim: Sex tech from women-led startups pops up at CES gadget show.
Example Output: 2

Example Input: Paragraph: An image that purports to show a screengrab from a medical journal was featured on a tweet that gained traction on January 15 2020.The tweet contains a capture of this citation:It says:Hormone replacement therapy has many nicknames among transfeminine people, including titty pills, titty skittles, smartitties, chicklets, anticistamines, mammary mints, life savers, tit tacs, breast mints, femme&m’s, antiboyotics, trans-mission fluid, and the Notorious H.R.T.“oh fuck this was in an actual medical journal I’m gonna cry lmao,” the user wrote.While it is legitimate, many of the users sharing it may not be aware of the context behind it. The citation was included in an article published by the McGill Journal of Law and Health, a publication covering healthcare-related law. The story itself is a first-person account by activist Florence Ashley regarding their experience seeking medical care both pre-and post-gender transition.Their listing of the nicknames for hormone replacement therapy (HRT) appears alongside a passage covering the temporary effects from stopping the treatment prior to reassignment surgery:I had to stop taking the hormones three weeks before surgery, give or take a few days. I was ill-prepared for this endeavour. Because hormones regulate emotions, amongst many other things, changes in hormonal regimen can have a heavy impact on mood stability and mental health. In my case, the fluctuations were large enough that I had to raise my dosage of antidepressant.A few months after surgery, my reflection in the mirror elicited an emotional reaction I had not yet grown accustomed to. After over a year on hormone replacement therapy, my body had changed in ways that finally began feeling comfortable. After decades of discontent, I was finally feeling at home in what I had previously described as a flesh prison. It had only taken a few weeks without hormones to lose what I estimated as six months of progress, noticeable in terms of fat redistribution, breast tissue loss, and changes to sexual functioning. The mirror served me a cruel reminder of this loss of self.In their paper, Ashley argues that current regulations covering disclosure of information between medical providers and transgender patients rely “on overly narrow conceptions of informed consent and underestimates the role that communal knowledge should play in health care.”Their own surgeon, for example, did not mention what the side effects would be of stopping HRT prior to surgery.“I would not have changed my mind about having surgery, it is true, but I could have done more to prepare had I known about the impact of ceasing hormone replacement therapy,” they wrote:Knowing in advance is crucial to psychological preparation and adaptation. Armed with knowledge, I could have scheduled appointments with my therapist, warned my loved ones about my increased need for support and softness, and refrained from in-person commitments. I did the latter two of those for a subsequent surgical procedure. Claim: "An article published in a medical journal makes reference to nicknames for hormone replacement therapy that included ""antiboyotics, trans-mission fluid, and the Notorious H.R.T."
Example Output: 2

Example Input: Paragraph: The story attempted to discuss cost by citing the difference in price between shoulder surgery ($13,000) and the PRP treatment ($1,000, in this case for two injections). This is sufficient enough for a Satisfactory rating, but barely. While this does give readers some idea of the possible cost difference in treatments, there is no assurance that the charges in the author’s case are typical for those for the general public. It is simply one single data point which is fairly useless to the public. And, since there is no evidence of benefit or how many shots one might require, cost could be all over the place. The story gives no information on quantified benefits measured in PRP research, and instead focuses only on the author’s experience. The only mention of potential harms in the story comes in this statement:  “The American Academy of Orthopedic Surgeons — which says PRP ‘holds great promise’ — describes the risk as minimal.”  That’s not acceptable given that there is no explanation of what those risks might be. Readers are left clueless when it comes to questions of potential harms. Simply put, the discussion on the quality of evidence here is at best minimal, just the experience of one patient who happens to be a writer for the Washington Post. The story does cite a “recent pilot study” from a Canadian clinic of just seven rotator cuff injury patients who underwent PRP therapy. It said the study “showed tissue healing in five of seven patients . . . as well as improvements in their pain and function.”  But the story offers no information on how much healing or what degree of pain reduction or function, information readers need to consider a new therapeutic approach. There is no discussion of the growing body of evidence that has yet to show PRP actually improves clinical results. High-quality research, including a Cochrane systematic review, shows no benefit from injecting PRP. As Cochrane’s review noted: “The quality of the evidence is very low, partly because most trials used flawed methods that mean their results may not be reliable….In terms of individual conditions, we were able to pool results from six studies and found no differences in long-term function between those who received PRT during rotator cuff surgery and those who did not.” When it comes to shoulder injuries like rotator cuff tears, the story does not disease monger. However, the author’s claim that a vaccination injection resulted in the shoulder tear was an unusual claim, and one that we’re dubious of. Along with quotes from the author’s physician (who has already posted the story on his website) there are quotes from a researcher who was involved in one small clinical trial on PRP. The inclusion of the researcher just barely squeaks by as sufficient to earn a Satisfactory rating here. However, the story would have been much stronger had the author interviewed an expert who disagrees with these two sources, which wouldn’t be hard to find given the Cochrane review and other systematic reviews that cast a less rosy glow on PRP. The story is basically touting a possible new therapy as an alternative to traditional rotator cuff surgery, but it does a poor job of comparing them in an evidence-based manner. The story explains that platelets are removed from a patient’s blood using a centrifuge, equipment readily available in most practices. It makes the point of advising readers to seek out practitioners who do the procedure frequently. The story suggests that the PRP procedure is becoming more available. The story does not make it clear that PRP is not a new treatment, and that has been studied for many years now, including in rotator cuff tears. This story does not rely on a news release. Claim: I’ll never go through shoulder surgery again, so here’s what I did
Example Output:
1